Pulmonary Aspergillosis Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Pulmonary Aspergillosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA

Airway ClearanceAllergic Bronchopulmonary AspergillosisABPA+1 more
Qianfoshan Hospital44 enrolled1 locationNCT07362667
Recruiting

PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value

Invasive Pulmonary Aspergillosis
University Hospital, Strasbourg, France100 enrolled1 locationNCT07313527
Recruiting

Influenza Associated Aspergillosis In-depth Investigation

Invasive Pulmonary AspergillosisInfluenza With Pneumonia
Universitaire Ziekenhuizen KU Leuven45 enrolled1 locationNCT03748069
Recruiting
Phase 2

Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options

Chronic Pulmonary Aspergillosis
Mundipharma Research Limited60 enrolled37 locationsNCT06794554
Recruiting

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis (ABPA)
Qianfoshan Hospital140 enrolled1 locationNCT07040332
Recruiting
Phase 2

iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine

Allergic Bronchopulmonary AspergillosisChronic Pulmonary AspergillosisPulmonary Aspergillosis
Radboud University Medical Center10 enrolled1 locationNCT06244979
Recruiting

Breath Analysis for the Detection of Invasive Fungal Infections

LeukemiaLeukemia, MyeloidLeukemia, Lymphoblastic+4 more
University of Zurich130 enrolled1 locationNCT06537726
Recruiting

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

Chronic Pulmonary Aspergillosis
Imperial College London100 enrolled3 locationsNCT06885905
Recruiting
Phase 2

Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study

AspergillosisChronic Pulmonary Aspergillosis
Manchester University NHS Foundation Trust50 enrolled1 locationNCT05653193
Recruiting
Phase 3

A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh300 enrolled1 locationNCT06174922
Recruiting
Phase 3

Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole

Chronic Pulmonary Aspergillosis
Poitiers University Hospital224 enrolled1 locationNCT03656081
Recruiting
Phase 3

A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis

Chronic Pulmonary AspergillosisCPAAspergilloma
Post Graduate Institute of Medical Education and Research, Chandigarh196 enrolled1 locationNCT06447402
Recruiting

Early Diagnosis of Invasive Lung Aspergillosis

Invasive Pulmonary AspergillosisRespiratory Infection
University Hospital Ostrava150 enrolled7 locationsNCT05860387